Magnolia extract containing compositions
US8445036B2 · kind B2 · utility
2Cited by
49References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2011 |
| Grant date | May 21, 2013 |
| Priority date | — |
| Expiry date | Feb 12, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/782
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method of treating telangiectasias on a person's skin comprising topically applying to skin in need of treatment a composition comprising magnolia bark extract.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.